Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | company profile
ACADIA Pharmaceuticals Inc. -Premium Company Profile (Datamonitor)
- Market: Healthcare and Medical
- Published Date: 14/12/2007
- Report Title: ACADIA Pharmaceuticals Inc. -Premium Company Profile
- Table of Contents: View Table of Contents
- Report Type: Company Profile
- Country: Global
- Number of Pages: 49
Introduction
ACADIA Pharmaceuticals is a clinical development stage biopharmaceutical company mainly focused on discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system (CNS) disorders utilizing its innovative R-SAT functional assay technology.
Scope
Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights
ACADIA Pharmaceuticals has a pipeline of drug candidates including: Pimavanserin, as a co-therapy for schizophrenia and for the treatment of Parkinson's disease psychosis; ACP-104, for treatment of schizophrenia; and a neuropathic pain program in Phase II development in collaboration with Allergan.
It derives 100% of its revenues from research and milestone payments under its collaboration agreements with strategic partners Allergan, Sepracor and The Stanley Medical Research Institute for the development of new drug candidates and therapeutics. During 2002-2006, it's total revenues increased at a CAGR of 7%, from $6 million to $8 million.
Reasons to Purchase
Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization
Scope
Highlights
Reasons to Purchase
Purchase Information
There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.
Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.
Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
